Human Biobanking Ownership - Global Trends, Estimates and Forecasts, Published: May 2016 Single User PDF: US$ 4160 Order this report by calling or Send an to with your contact details and questions if 1© ReportsnReports.com / Contact

Human Biobanking Ownership - Global Trends, Estimates and Forecasts, Global Market Watch: Primarily supported by ownership types; Private Biobanks and Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to witness a value of US$37.1 billion by Geographical analysis for Private Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from Asia-Pacific region during the analysis period North America is not way behind with a CAGR of 9.95% followed by Europe at 9.56% respectively. Report Focus: The report “Human Biobanking Ownership - Global Trends, Estimates and Forecasts, ” reviews the latest human biobanking market trends with a perceptive attempt to disclose the near- future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on: Emerging market trends, Advancements in the technological space, Market demand of the segments (by-region), Key growth areas and market size, Key competitor’s Edge Access Complete Report at ownership-global-trends-estimates-and-forecasts html. ownership-global-trends-estimates-and-forecasts html Order this report by calling or Send an to with your contact details and questions if any. 2© ReportsnReports.com / Contact

Human Biobanking Ownership - Global Trends, Estimates and Forecasts, Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. The analysis primarily deals with human biobanking ownership market. Further, the subdivided categories include: Private Banks: Disease-Based Banks, Population-Based Banks and Academics Public Banks: Disease-Based Banks, Population-Based Banks, Academics Hospitals, Biotechnology & Pharmaceutical Companies, Diagnostics, Transplantation and Biobank Storage Companies Newborns, Adults or Pregnant Women Medical Institutions, Research and Forensics Request for sample at Order this report by calling or Send an to with your contact details and questions if any. 3© ReportsnReports.com / Contact

Human Biobanking Ownership - Global Trends, Estimates and Forecasts, The period considered for the human biobanking ownership market analysis is The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years. More than 1270 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 138 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed. Inquiry for Discount at Order this report by calling or Send an to with your contact details and questions if any. 4© ReportsnReports.com / Contact

Human Biobanking Ownership - Global Trends, Estimates and Forecasts, List of Key Companies North America: Vericel Corporation, Acorda Therapeutics, Inc., Alpha Cord, Inc., Affymetrix, Inc., Cellerant Therapeutics, Inc., Cryo-Cell International, Inc., Mesoblast, Inc., Atgc Labs, Autogen, Inc., Barber Nichols, Beckman Coulter, Inc., Biocision,U.S. Stem Cell, Inc., Biolife Solutions, Inc.,Biological Specimen Inventory System, Biomatrica, Inc., Biostorage, Llc., Cti Biopharma Corp., Chart Industries, Inc., Charter Medical, Ltd., Corcell, Inc., Cord Blood Registry, Core Dynamics (Usa), Inc., Cryolife, Inc., Cryomagnetics, Inc., Cryoplus, Inc. and more. Europe: Panasonic Biomedical Sales Europe B.V, Epistem Ltd., Aqix, B & C Group, Bbmri, Lifegene, Biobank Ireland Trust, Biokryo Gmbh, Biorep Srl P.Iva, Biostorage Technologies, Inc., Boehringer Ingelheim, Gmbh, Cells4life, Ltd., Cryo Bio System, Cryo-Save, Ag,Decode Genetics, Ge Healthcare Life Sciences, Genesisbps, Highres Biosolutions, Indivumed, Lifegene Biobank, Lifelines Cohort And Biobank (Lifelines) and more. Asia-Pacific: Cole Parmer Instrument, Co., Cordlife Pte., Ltd., Cryocord Sdn. Bhd., Cryologic Pty. Ltd., Genesearch, Ocimum Biosolutions, Reliance Life Sciences, China Cord Blood Corporation Rest Of World: Babycell Egypt, Gamida Cell Ltd. Buy a copy of Order this report by calling or Send an to with your contact details and questions if any. 5© ReportsnReports.com / Contact

About ReportsnReports ReportsnReports.comReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in- depth market research studies of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Contact: Ritesh Tiwari Maharashtra, India. Tel: © ReportsnReports.com / Contact